Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
<h4>Objectives</h4>Macrolides are generally considered to be the drugs of choice for treatment of patients with Mycoplasma pneumoniae infection. However, macrolide-resistant M. pneumoniae has been emerging since about 2000. The Smart Gene® system (MIZUHO MEDY Co., Ltd., Tosu, Japan) is a...
Guardado en:
Autores principales: | Nobuhisa Ishiguro, Rikako Sato, Toshihiko Mori, Hiroshi Tanaka, Mitsuo Narita, Takashi Nagano, Masato Owaku, Kensuke Miyajima, Atsushi Manabe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d34ac3c3b04407ea84290c83899f472 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genotype and mutation patterns of macrolide resistance genes of Mycoplasma pneumoniae from children with pneumonia in Qingdao, China, in 2019
por: Fa-Chun Jiang, et al.
Publicado: (2021) -
A 3D-Printed Microfluidic Device for qPCR Detection of Macrolide-Resistant Mutations of <i>Mycoplasma pneumoniae</i>
por: Anyan Wang, et al.
Publicado: (2021) -
Detection of Mycoplasma Contamination in Transplanted Retinal Cells by Rapid and Sensitive Polymerase Chain Reaction Test
por: Sunao Sugita, et al.
Publicado: (2021) -
Context-specific action of macrolide antibiotics on the eukaryotic ribosome
por: Maxim S. Svetlov, et al.
Publicado: (2021) -
Structural and functional insights into esterase-mediated macrolide resistance
por: Michał Zieliński, et al.
Publicado: (2021)